Literature DB >> 6184652

Retrograde transport of doxorubicin (adriamycin) in peripheral nerves of mice.

L Bigotte, Y Olsson.   

Abstract

Doxorubicin (adriamycin) is a fluorescent compound which is widely used in the treatment of malignant tumors due to its capacity to bind and influence the DNA in the nucleus of cells. We have now observed that the compound after injection into a skeletal muscle of adult mice is transported to the corresponding nerve cell bodies, i.e. can be used as a retrograde tracer in neuroanatomical and neuropathological research. Six hours after injection into the tongue nerve cell nuclei were labeled in the hypoglossal nuclei of the brainstem. The fluorescent tracer had the same distribution as the chromatin. Glial nuclei in the vicinity of the hypoglossal neurons were also labeled presumably due to a transfer from the neurons to the glial cells during life or during the histochemical procedure. Since doxorubicin is also neurotoxic it might be a useful tool in neurobiological research, particularly if the labeled neurons later on will show toxic effects. In this way the compound could be used in models for experimental motor neuron disease and provide a means by which retrograde fluorescent tracing and a degeneration method can be combined for studies on various neuronal systems.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6184652     DOI: 10.1016/0304-3940(82)90296-8

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  13 in total

1.  Doxorubicin-induced central nervous system toxicity and protection by xanthone derivative of Garcinia mangostana.

Authors:  J Tangpong; S Miriyala; T Noel; C Sinthupibulyakit; P Jungsuwadee; D K St Clair
Journal:  Neuroscience       Date:  2010-11-11       Impact factor: 3.590

2.  Uptake of gentamicin by vestibular efferent neurons and superior olivary complex after transtympanic administration in guinea pigs.

Authors:  Yi-Bo Zhang; Ru Zhang; Wei-Feng Zhang; Peter S Steyger; Chun-Fu Dai
Journal:  Hear Res       Date:  2011-10-31       Impact factor: 3.208

3.  Effects of retrograde axonal transport of Ricinus communis agglutinin I on neuroma formation.

Authors:  I Nennesmo; K Kristensson
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

4.  Formation of microglia-derived brain macrophages is blocked by adriamycin.

Authors:  M B Graeber; W J Streit; G W Kreutzberg
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

5.  Multiple impairments of cutaneous nociceptor function induced by cardiotoxic doses of Adriamycin in the rat.

Authors:  Krisztina Boros; Gábor Jancsó; Mária Dux; Zoltán Fekécs; Péter Bencsik; Orsolya Oszlács; Márta Katona; Péter Ferdinandy; Antal Nógrádi; Péter Sántha
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-06-24       Impact factor: 3.000

6.  Cytofluorescence localization of adriamycin in the nervous system. IV. cellular uptake of the drug in peripheral nerve following various modes of injection to bypass the blood-nerve and the perifascicular barriers.

Authors:  L Bigotte; Y Olsson
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

7.  Fluorescence-microscopic localization of in vivo injected ethidium bromide in the nervous system of the mouse.

Authors:  K Cesarini; L Bigotte; Y Olsson
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

8.  Cytotoxic effects of adriamycin on mouse hypoglossal neurons following retrograde axonal transport from the tongue.

Authors:  L Bigotte; Y Olsson
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

9.  Cytofluorescence localization of propidium iodide injected intravenously into the nervous system of the mouse.

Authors:  S T Hussain; A Attilo; L Bigotte; K Cesarini; Y Olsson
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

10.  Cytofluorescence localization of ethidium bromide in the nervous system of the mouse. I. Ethidium bromide: its distribution in regions within and without the blood-brain barrier after intravenous injection.

Authors:  K Cesarini; A Atillo; L Bigotte; S T Hussain; Y Olsson
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.